Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
D058186:Acute Kidney Injury / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001315:Australia; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005921:Glomerulonephritis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000628:therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D006435:Renal Dialysis; D012621:Seasons; D013256:Steroids / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D013256:Steroids; D014859:Warfarin; D004176:Dipyridamole; D003520:Cyclophosphamide; D005337:Fibrin; D006493:Heparin; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine